The U.S. Government Is Betting Billions on Quantum Computing. These 3 Stocks Are the Biggest Winners.

Two Trump executive orders put quantum computing and post-quantum cryptography at the center of U.S. policy, including a 2028 target for a scientifically relevant quantum computer and migration deadlines of 2030-2031 for critical federal systems. IBM is positioned to benefit from its proposed $1 billion CHIPS Act funding and more than $10 billion of planned quantum investment, while GlobalFoundries has a $375 million quantum manufacturing initiative. Palo Alto Networks could see longer-term demand from mandated PQC upgrades as the market is projected to rise from $420 million in 2025 to $2.84 billion by 2030.

Analysis

The market is likely underappreciating that this is not a binary “quantum winners” trade; it is a procurement and supply-chain repricing across the entire stack. The first-order beneficiaries are the firms that control scarce bottlenecks—foundry capacity, packaging, test, cryogenics, error-correction tooling, and enterprise integration—because federal timelines force spending even before the technology is economically elegant. That tends to favor established cash-generators over pre-revenue names, and it also means the second derivative winners may be the boring infrastructure vendors that become embedded in standards and vendor qualification cycles.

IBM’s setup is more durable than a simple quantum option because the strategic value is not just the lab roadmap, but the ability to shape enterprise architecture around compliance-driven modernization. If federal and regulated buyers need PQC-ready systems, IBM can monetize the migration through consulting, managed infrastructure, and software attach, while quantum becomes a credibility wedge rather than the P&L story. The hidden risk is execution dispersion: if milestones slip, the stock could de-rate from “strategic national asset” back toward a mature IT services multiple.

GlobalFoundries is the cleaner asymmetry, but only if the market continues to value capacity scarcity rather than ultimate architecture winner. The real optionality is that multiple qubit modalities will likely coexist longer than bulls expect, which keeps specialized manufacturing valuable even if one approach disappoints. The contrarian risk is that the quantum supply chain remains subsidy-dependent; if federal follow-through slows after the headlines, ordering cadence could lag the narrative by 12-18 months.

Key Decisions for Investors

• Long PANW on a 6-12 month view; buy on any broad software pullback and target a compliance-driven rerating as federal PQC procurement budgets become visible. Risk/reward: asymmetric because the revenue is pull-forward, while downside is bounded by existing platform durability.
• Long IBM vs. short a basket of slower-moving legacy IT services names over 3-6 months; thesis is that IBM gets an enterprise-security modernization premium while peers lack a comparable quantum/PQC narrative. Use a modest gross exposure because the upside is multiple expansion, not rapid fundamental inflection.
• Long GFS as a supply-chain bottleneck play; hold 12-24 months and expect multiple expansion if quantum manufacturing remains multi-architecture. Stop out if CHIPS-funded demand is delayed or if quantum capex evidence does not show up in order flow within 2-3 quarters.
• Pair trade: long IBM / short pre-revenue quantum pure plays as a quality-vs-hype expression. This isolates policy-driven monetization against names that need perfect execution and continued subsidy flow.
• Consider a call spread in PANW rather than outright equity for a 6-9 month catalyst window; the mandate creates a measurable floor for demand, but valuation can still compress if broader software multiples roll over.